Definition of Substance and Non-substance Addiction.
Zou Z, Wang H, d'Oleire Uquillas F, Wang X, Ding J, Chen H.
Adv Exp Med Biol. 2017;1010:21-41. doi: 10.1007/978-981-10-5562-1_2.
What Is Addiction? History, Terminology, and Core Concepts.
Olsen Y.
Med Clin North Am. 2022 Jan;106(1):1-12. doi: 10.1016/j.mcna.2021.08.001.
Substance Use Disorders and Addiction: Mechanisms, Trends, and Treatment Implications.
Kalin NH.
Am J Psychiatry. 2020 Nov 1;177(11):1015-1018. doi: 10.1176/appi.ajp.2020.20091382.
Editorial: Public health, suicide, and substance addiction.
Saleem SM, Alkasaby M, Shoib S.
Front Public Health. 2023 Dec 19;11:1343708. doi: 10.3389/fpubh.2023.1343708. eCollection 2023.
Neuromodulation for substance addiction in human subjects: A review.
Bari A, DiCesare J, Babayan D, Runcie M, Sparks H, Wilson B.
Neurosci Biobehav Rev. 2018 Dec;95:33-43. doi: 10.1016/j.neubiorev.2018.09.013. Epub 2018 Sep 27.
Biochemical Diagnosis in Substance and Non-substance Addiction.
Shen W, Liu H, Xie X, Liu H, Zhou W.
Adv Exp Med Biol. 2017;1010:169-202. doi: 10.1007/978-981-10-5562-1_9.
Addiction is a brain disease, and it matters.
Leshner AI.
Science. 1997 Oct 3;278(5335):45-7. doi: 10.1126/science.278.5335.45.
Neuroscience of Addiction: Relevance to Prevention and Treatment.
Volkow ND, Boyle M.
Am J Psychiatry. 2018 Aug 1;175(8):729-740. doi: 10.1176/appi.ajp.2018.17101174. Epub 2018 Apr 25.
Reward processing in obesity, substance addiction and non-substance addiction.
García-García I, Horstmann A, Jurado MA, Garolera M, Chaudhry SJ, Margulies DS, Villringer A, Neumann J.
Obes Rev. 2014 Nov;15(11):853-69. doi: 10.1111/obr.12221. Epub 2014 Sep 29.
Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.
Kim S, Kwok S, Mayes LC, Potenza MN, Rutherford HJV, Strathearn L.
Ann N Y Acad Sci. 2017 Apr;1394(1):74-91. doi: 10.1111/nyas.13140. Epub 2016 Aug 10.
